Anders Dyhr Toft waves goodbye to Novo Nordisk after 18 years to become the CMO of Synact: "It's going to be more DIY-based"

After almost two decades working for Novo Nordisk, Anders Dyhr Toft changes the scenery of his professional life to biotech company Synact Pharma to be the new CMO. According to the person in question, he felt the need to try out a different culture and pacing, as well as a new level of risk-taking.
Synact Pharma's new Chief Medical Officer Anders Dyhr Toft | Photo: Per Fledelius / PR
Synact Pharma's new Chief Medical Officer Anders Dyhr Toft | Photo: Per Fledelius / PR
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN

A freer bird now, but with smaller wings.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading